87.35
price up icon0.45%   0.39
pre-market  Vorhandelsmarkt:  87.58   0.23   +0.26%
loading

Alcon Inc Aktie (ALC) Neueste Nachrichten

pulisher
Jul 20, 2025

Is Alcon Inc. a good long term investmentRapidly growing investment returns - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Alcon Inc. stockSignificant capital appreciation - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Alcon Inc. stock priceSuperior stock selection - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Alcon Inc. Stock Analysis and ForecastRapid profit acceleration - Autocar Professional

Jul 20, 2025
pulisher
Jul 17, 2025

September 19th Options Now Available For Alcon (ALC) - Nasdaq

Jul 17, 2025
pulisher
Jul 14, 2025

Alcon Stock Gains Following UNITY VCS' Approval in Canada - MSN

Jul 14, 2025
pulisher
Jul 12, 2025

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients - Ophthalmology Times Europe

Jul 12, 2025
pulisher
Jul 12, 2025

Stifel reiterates Buy rating on Alcon stock, maintains $100 price target - Investing.com Nigeria

Jul 12, 2025
pulisher
Jul 11, 2025

Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions - Eyes On Eyecare

Jul 11, 2025
pulisher
Jul 10, 2025

Stifel reiterates Buy rating on Alcon stock, maintains $100 price target By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Alcon Adds Noninvasive Treatment Solution, Acquires LumiThera | Business | Jul 2025 - Photonics Spectra

Jul 10, 2025
pulisher
Jul 10, 2025

Alcon Names Julie M. Brewer to its Executive Leadership Team as SVP, President, Global Franchises - VisionMonday.com

Jul 10, 2025
pulisher
Jul 09, 2025

Alcon sees the light with Lumithera buy for dry AMD - BioWorld MedTech

Jul 09, 2025
pulisher
Jul 09, 2025

Alcon’s vitreoretinal-cataract system receives Health Canada approval By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Alcon to acquire LumiThera for dry AMD treatment device - MSN

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon to purchase LumiThera - Eyes On Eyecare

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon's Unity VCS Gets Health Canada Approval - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon snaps up LumiThera for light-based AMD treatment - Optics.org

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon Gets Health Canada Approval on Unity Vitreoretinal Cataract System - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon’s vitreoretinal-cataract system receives Health Canada approval - Investing.com

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon : Names Julie M. Brewer to its Executive Leadership Team as SVP, President, Global Franchises - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

La dernière technologie chirurgicale révolutionnaire d’Alcon, Unity VCS, reçoit l’approbation de Santé Canada - New Castle News

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon Eyes Vitreoretinal Surgery Market Expansion in LumiThera Deal - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon to acquire LumiThera and its dry AMD light therapy device - Investing.com Australia

Jul 08, 2025
pulisher
Jul 07, 2025

Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon's Bold Bet on Light Therapy: A New Dawn for Dry AMD and Retinal Dominance - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon To Acquire LumiThera - citybiz

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD - Ophthalmology Times

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon To Acquire LumiThera And Its Photobiomodulation Device - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon to acquire LumiThera and its dry AMD light therapy device By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD) - Business Wire

Jul 07, 2025
pulisher
Jul 04, 2025

Do Options Traders Know Something About Alcon Stock We Don't? - MSN

Jul 04, 2025
pulisher
Jul 02, 2025

Is it Apt to Retain Alcon Stock in Your Portfolio for Now? - MSN

Jul 02, 2025
pulisher
Jul 02, 2025

LENSAR Stockholders Approve Merger with Alcon Research - TipRanks

Jul 02, 2025
pulisher
Jun 26, 2025

Alcon Canada Earns Global Recognition as a Top Employer - Yahoo Finance

Jun 26, 2025
pulisher
Jun 20, 2025

Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL - Yahoo Finance

Jun 20, 2025
pulisher
Jun 18, 2025

Alcon and Merit Medical: Creating Regulatory and Quality Business Value with AI - Veeva

Jun 18, 2025
pulisher
Jun 18, 2025

Should Weakness in Alcon Inc.'s (VTX:ALC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

Jun 18, 2025
pulisher
Jun 12, 2025

GLP-1 Drugs Show Promise in Reducing Risk of Age-Related Eye Diseases - Managed Healthcare Executive

Jun 12, 2025
pulisher
Jun 09, 2025

Alcon Gets First FDA Approval Since Novartis Spinoff - Orange County Business Journal

Jun 09, 2025
pulisher
Jun 09, 2025

Alcon’s Tryptyr Adds Growth, But Valuation Keeps Shares On 'Hold' (NYSE:ALC) - Seeking Alpha

Jun 09, 2025
medical_instruments_supplies RMD
$257.92
price up icon 0.58%
medical_instruments_supplies BDX
$178.85
price down icon 1.13%
medical_instruments_supplies WST
$210.89
price down icon 4.83%
medical_instruments_supplies COO
$72.63
price down icon 0.86%
$63.99
price down icon 0.05%
Kapitalisierung:     |  Volumen (24h):